SNPX Archived Articles
Synaptogenix (NASDAQ:SNPX): Navigating the Complexities of Neurodegenerative Disorder Therapeutics
Published on November 17, 2024
Synaptogenix, Inc. (NASDAQ:SNPX): Advancing Neurological Treatments with Bryostatin-1
Published on September 24, 2024